With over 20 years of experience working with microbial systems, Wacker Biotech GmbH is a preferred partner for the contract-manufacturing of therapeutic proteins (biologics). Our focus is on the development of stable, high-efficiency processes, and GMP-compliant production in our certified multi-functional facility. Our customers include both mid-sized and globally-active pharma and biotech companies.

Wacker Biotech's experience with therapeutic proteins spans back to the 1980's, when the key focus was on developing interferon alpha. Biopharmaceuticals have been commercially developed and produced since 1999. Back then, ProThera GmbH was established as a spin-off of the state-owned Hans Knöll Institute in Jena. Wacker Biotech is a wholly-owned WACKER Group subsidiary, operating since early 2005 as the direct successor of ProThera GmbH.